Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

RADIATION(1)

MIXED(1)

DRUG(1)

Pembrolizumab

1 trial

phase_1_2

washington-university-school-of-medicine

Hypofractionated Stereotactic Body Radiotherapy (SBRT)

1 trial

phase_1_2

washington-university-school-of-medicine

Ficerafusp alfa

1 trial

phase_1_2

washington-university-school-of-medicine

3 unique interventions3 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07552558Phase 1/2Not Yet Recruiting

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell CarcinomaHPV-Negative Squamous Cell Carcinoma

Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Squamous Cell Carcinoma of Head and Neck1 HPV-Negative Squamous Cell Carcinoma1

Affiliations

Washington University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ari Rosenberg, MD

University of Chicago

Moderately Similar

5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckHPV-Negative Squamous Cell Carcinoma

Similarity Score30%

Sana Karam, MD, PhD

Washington University School of Medicine

1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckHPV-Negative Squamous Cell Carcinoma

Worked with same sponsors:

Bicara TherapeuticsWashington University School of Medicine

Collaborated on 1 trial

Similarity Score24%

Vincent Chung

City of Hope Medical Center

9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Dan Zandberg, MD

UPMC Hillman Cancer Center

6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Ezra Cohen, MD

University of Chicago

6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Jared Weiss, MD

University of North Carolina, Chapel Hill

7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Amar Patel, MD

Celgene

5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Anna Spreafico, MD

Princess Margaret Cancer Centre

6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07552558Phase 1/2PrincipalInvestigator

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell CarcinomaHPV-Negative Squamous Cell Carcinoma

Not Yet Recruiting

All 1 trials loaded